Rockwell Medical, Inc. (RMTI) vs Talphera, Inc. (TLPH)

Rockwell Medical, Inc. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $60.7M against $34.5M — 1.8× the size. Rockwell Medical, Inc. grew revenue faster over the last twelve months: −21.1% against −73.1%. Talphera, Inc. has the higher net margin (0.00% vs −7.33%) and the higher return on invested capital (0.00% vs −14.6%). Across the 18 metrics below, Rockwell Medical, Inc. leads on 10 and Talphera, Inc. on 8.

Valuation

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.48 209.21 2.25
P/B 0.95 6.19 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.25 183.86 2.56
Earnings yield (15.95%) (22.88%) (2.99%)
Free cash flow yield (2.95%) (10.82%) 0.00%

Profitability

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
Gross margin 17.71% 100.00% 53.94%
Operating margin (6.52%) 0.00% 0.00%
Net margin (7.33%) 0.00% 0.00%
Free cash flow margin 2.47% 0.00% 0.00%
Return on equity (15.53%) (143.36%) (0.40%)
Return on assets (9.32%) (69.60%) (3.32%)
Return on invested capital (14.58%) 0.00% 0.00%

Growth

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (21.12%) (73.07%) 10.01%
EPS growth (last fiscal year) (870.87%) 32.00% —
Revenue growth, 5-year CAGR 2.17% (58.55%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.26 0.00 0.05
Current ratio 3.25 4.29 2.31
Net debt to EBITDA 7.40 1.50 0.85

Dividend

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
Market cap 34.54m 60.73m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack